Come up with a name for your new list and we'll add to it:
Apthera was acquired by
RXi Pharmaceuticals on April 19, 2011.
Apthera is a privately-held biotechnology company developing a pipeline of peptide based immune-therapies. In April 2011, Apthera was acquired by RXi Pharmaceuticals. The valuation of Apthera was $7.…